rs149540339
Variant summary
Our verdict is Likely benign. The variant received -3 ACMG points: 0P and 3B. BP4_ModerateBP6
The NM_001005373.4(LRSAM1):āc.1225C>Gā(p.Gln409Glu) variant causes a missense change. The variant allele was found at a frequency of 0.000437 in 1,614,020 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001005373.4 missense
Scores
Clinical Significance
Conservation
Publications
- Charcot-Marie-Tooth disease axonal type 2PInheritance: AR, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -3 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| LRSAM1 | NM_001005373.4 | c.1225C>G | p.Gln409Glu | missense_variant | Exon 17 of 26 | ENST00000300417.11 | NP_001005373.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000375 AC: 57AN: 152164Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000430 AC: 108AN: 251446 AF XY: 0.000397 show subpopulations
GnomAD4 exome AF: 0.000444 AC: 649AN: 1461856Hom.: 0 Cov.: 32 AF XY: 0.000474 AC XY: 345AN XY: 727236 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000375 AC: 57AN: 152164Hom.: 0 Cov.: 32 AF XY: 0.000390 AC XY: 29AN XY: 74336 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Charcot-Marie-Tooth disease axonal type 2P Uncertain:1Benign:2Other:1
GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. -
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -
- -
The LRSAM1 c.1225C>G; p.Gln409Glu variant (rs149540339; ClinVar Variation ID: 365027) is reported in the literature in three individuals included in a cohort of patients affected with Charcot-Marie-Tooth disease; however, further evidence of causality was not presented (Volodarsky 2021). This variant is found in non-Finnish European population with an allele frequency of 0.07% (96/129166 alleles) in the Genome Aggregation Database (v2.1.1). Computational analyses predict that this variant is neutral (REVEL: 0.067). Due to limited information, the clinical significance of this variant is uncertain at this time. References: Volodarsky M et al. Comprehensive genetic sequence and copy number analysis for Charcot-Marie-Tooth disease in a Canadian cohort of 2517 patients. J Med Genet. 2021 Apr;58(4):284-288. PMID: 32376792. -
not provided Benign:2
LRSAM1: BP4 -
This variant is associated with the following publications: (PMID: 32376792) -
not specified Uncertain:1
Variant summary: LRSAM1 c.1225C>G (p.Gln409Glu) results in a conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00043 in 251446 control chromosomes, predominantly at a frequency of 0.00076 within the Non-Finnish European subpopulation in the gnomAD database. This frequency is not significantly higher than estimated for a pathogenic variant in LRSAM1 causing Charcot-Marie-Tooth disease axonal type 2P-AR (0.00043 vs 0.0011), allowing no conclusion about variant significance. c.1225C>G has been reported in the literature in individuals affected with Charcot-Marie-Tooth disease without strong evidence for causality (Volodarsky_2021). These report(s) do not provide unequivocal conclusions about association of the variant with Charcot-Marie-Tooth disease axonal type 2P-AR. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication has been ascertained in the context of this evaluation (PMID: 32376792). ClinVar contains an entry for this variant (Variation ID: 365027). Based on the evidence outlined above, the variant was classified as uncertain significance. -
Inborn genetic diseases Uncertain:1
The p.Q409E variant (also known as c.1225C>G), located in coding exon 15 of the LRSAM1 gene, results from a C to G substitution at nucleotide position 1225. The glutamine at codon 409 is replaced by glutamic acid, an amino acid with highly similar properties. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Based on the supporting evidence, this variant is unlikely to be causative of autosomal dominant Charcot-Marie-Tooth disease, type 2P (CMT2P); however, its contribution to the development of autosomal recessive CMT2P is uncertain. -
Charcot-Marie-Tooth disease Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at